Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

EKTAY Relative to the S&P 500

EKTAY Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Elekta AB ADR (OTCMKT:EKTAY) seasonal charts above shows that a Buy Date of November 25 and a Sell Date of February 17 has resulted in a geometric average return of 0.7% above the benchmark rate of the S&P 500 Total Return Index over the past 16 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 16 years by an average of 7.62% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm’s products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

To download EKTAY seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: EKTAY